Back to dashboard
All PlansCoverageLow impact

Transcatheter Aortic Valve Implantation for Aortic Stenosis

Blue Cross & Blue Shield of Mississippi·MS · Cardiology, Cardiothoracic Surgery·Medical Policy
Effective date
Not stated
We identified it
Jun 20, 2026
Days to comply

Summary

This is a comprehensive medical policy document for Transcatheter Aortic Valve Implantation (TAVI/TAVR) for aortic stenosis that provides background information and lists FDA-approved devices. The policy appears to be informational rather than announcing specific coverage or billing changes.

Action Required

Action needed
Review policy document to understand TAVI/TAVR coverage criteria and FDA-approved devices. No immediate billing system changes required as this appears to be an informational policy update without specific coverage or coding changes.